Immunohistochemistry staining of Ki67 showed decreased cell proliferation in the combination group compared with that in the solo treatment group, indicating that Quinalizarin had a notable effect on tumor radiosensitivity (Fig. 8C). This evidence concerns the gene MKI67 and neoplasm.